Large survey shows wide variability in risk tolerance, high levels of risk aversion
Treating symptoms before they gain momentum; 50,000 patients needed for clinical trials
Findings suggest an edge for fingolimod over dimethyl fumarate
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy